The post This Dividend Stock Down 20% is My Contrarian Buy of the Year appeared first on The Motley Fool Canada.

AbbVie reported mixed Q2 2024 results, adding to my concerns of its growth potential. Looking ahead, I see continued pressure for Humira sales and also increasing in-house R&D expenses. These issues ...

These 3 under-the-radar stocks yield up to 7.3%. With rents poised to soar and LNG exports booming, their high income yields ...

Key Insights The projected fair value for Spectra Products is CA$0.20 based on 2 Stage Free Cash Flow to Equity ...

Yield is defined as cash dividends paid over the past four quarters, divided by share price. For many investors, it is tied with the price/earnings ratio at the top of investors’ go-to list. Yield is ...